Literature DB >> 12323177

Plasma catecholamines in Buerger's disease: effects of cigarette smoking and surgical sympathectomy.

R Roncon-Albuquerque1, P Serrão, R Vale-Pereira, J Costa-Lima, R Roncon-Albuquerque1.   

Abstract

OBJECTIVES: to study the influence of tobacco exposure and sympathectomy on basal sympathoadrenal function of patients with Buerger's disease.
DESIGN: plasma catecholamines were measured before and after smoking, in patients with Buerger's disease (n=13), in patients with Buerger's disease submitted to surgical bilateral lumbar sympathectomy (n=13), and in healthy volunteers (n=16).
MATERIALS AND METHODS: venous blood samples were collected before and 2h after smoking one cigarette (0.9mg nicotine). Plasma concentrations (pg/ml) of dihydroxiphenylalanine (pL-DOPA), noradrenalin (pNA), adrenalin (pAD) and 3,4-dihydroxiphenylacetic acid (pDOPAC) were determined.
RESULTS: Buerger's patients have low basal plasma catecholamines compared to volunteers: pNA (501 (196-927) vs 1858 (968-3663)) and pAD (71 (31-109) vs 193 (116-334)). Sympathectomy increased pL-DOPA, pAD and pDOPAC, but not pNA. After smoking, pNA only decreased in volunteers (1858 (968-3663) vs 1064 (535-2393)). In Buerger+sympathectomy group, smoking lowered pAD (700 (58-3379) vs 278 (54-429)).
CONCLUSIONS: in Buerger's disease there is an impairment of sympathoadrenal function with an altered peripheral adrenergic response to cigarette smoking. Patients submitted to sympathectomy have high pAD, but this benefit is reversed after smoking. This might be clinically relevant given the association between cigarette smoking and the manifestations of Buerger's disease and the controversy on the effectiveness of sympathectomy in the management of the disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12323177     DOI: 10.1053/ejvs.2002.1721

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  6 in total

1.  Buerger's disease (Thromboangiitis obliterans): a diagnostic challenge.

Authors:  Vanda Cristina Jorge; Ana Carolina Araújo; Carla Noronha; António Panarra; Nuno Riso; Manuel Vaz Riscado
Journal:  BMJ Case Rep       Date:  2011-09-13

2.  Etiopathogenesis, clinical diagnosis and treatment of thromboangiitis obliterans - current practices.

Authors:  Edwaldo Edner Joviliano; Renata Dellalibera-Joviliano; Marcelo Dalio; Paulo Rb Evora; Carlos E Piccinato
Journal:  Int J Angiol       Date:  2009

3.  Nails Involvement in Winiwarter-Buerger Disease.

Authors:  Michela V R Starace; Aurora Alessandrini; Antonella Tosti; Bianca Maria Piraccini
Journal:  Skin Appendage Disord       Date:  2021-09-21

4.  The Imbalance among Oxidative Biomarkers and Antioxidant Defense Systems in Thromboangiitis Obliterans (Winiwarter-Buerger Disease).

Authors:  Hiva Sharebiani; Bahare Fazeli; Rosanna Maniscalco; Daniela Ligi; Ferdinando Mannello
Journal:  J Clin Med       Date:  2020-04-07       Impact factor: 4.241

Review 5.  Thromboangiitis obliterans (Buerger's disease).

Authors:  Ignacio J Rivera-Chavarría; José D Brenes-Gutiérrez
Journal:  Ann Med Surg (Lond)       Date:  2016-03-29

6.  Endothelial dysfunction in patients with Buerger disease.

Authors:  Kimihiro Igari; Toshifumi Kudo; Takahiro Toyofuku; Yoshinori Inoue
Journal:  Vasc Health Risk Manag       Date:  2017-08-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.